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Abstract
To investigate the impact of insulin secretion on pregnancy outcome, we studied 102 patients at risk for 
glucose intolerance  between 28 and 34 weeks of gestation.  All  patients  had a 3-hour oral  glucose 
tolerance test (OGTT, 100 g glucose), and glucose and insulin plasma levels were assayed: 32 patients 
had a gestational diabetes (GDM); 25 had an impaired gestational glycemic tolerance (IGGT), and 45 
with normal OGTT constituted the control group. No significant difference between groups was seen 
for  pregnancy  outcome.  Based  on  the  mean  +/-  2  SD  of  insulin  secretion  of  the  control  group, 
IGGT/GDM patients were classified as normoinsulinemic (34 patients), hyperinsulinemic (17 patients), 
or hypoinsulinemic (6 patients). The hyperinsulinemic IGGT/ GDM group showed a greater incidence 
of pregnancy-induced hypertension (p < 0.03), while the percentile birth weight was significantly lower 
(p < 0.01) with respect to normo-hypoinsulinemic patients. Moreover a higher glucose/ insulin ratio 
was significantly related to birth weight (p < 0.01). Our results suggest an impact of insulin secretion 
on pregnancy outcome and support the importance of determining the insulinemic pattern in pregnant 
patients at risk for glucose intolerance.
